Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Sue Hughes

    News

    Cardiologists can perform stroke thrombectomy to fill ‘unmet need’

    Author:
    Sue Hughes
    Publish date: April 19, 2021

    Interventional cardiologists can competently perform stroke thrombectomy after training, with outcomes similar to those of neuroradiology centers...

    • Read More

    News

    COVID vaccine ‘side effect’ or functional neurologic disorder?

    Author:
    Sue Hughes
    Publish date: April 15, 2021

    “It is not the substance in the vaccine that is causing the condition, but the common side effects that can...

    • Read More

    News

    Novel antiplatelet drug: Hope for efficacy without bleeding?

    Author:
    Sue Hughes
    Publish date: April 12, 2021

    A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events...

    • Read More

    News

    Is there a need for tPA before thrombectomy in patients with stroke?

    Author:
    Sue Hughes

    The MR CLEAN NO IV trial failed to show superiority or noninferiority of direct endovascular treatment over intravenous tPA followed by...

    • Read More

    News

    AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?

    Author:
    Sue Hughes
    Publish date: April 2, 2021

    The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.

    • Read More

    News

    Meta-analysis supports late thrombectomy in selected stroke patients

    Author:
    Sue Hughes

    For every 100 patients treated with thrombectomy, 33 will have less disability, and 27 will achieve an independent level of functioning.

    • Read More

    News

    Direct transfer to angiography improves outcome in large-vessel stroke

    Author:
    Sue Hughes
    Publish date: March 23, 2021

    Patients who were taken directly to the angiography suite, bypassing the ED, received endovascular treatment faster and had better outcomes.

    • Read More

    News

    Dose-related AFib risk with omega-3 fatty acids?

    Author:
    Sue Hughes
    Publish date: March 19, 2021

    The VITAL-RHYTHM study, showing no significant effect of low-dose omega-3 fatty acids or vitamin D on AFib risk, has been published. A look at...

    • Read More

    News

    Type 2 diabetes linked to increased risk for Parkinson’s

    Author:
    Sue Hughes

    Both observational and genetic data have provided “convincing evidence” that T2D predisposes people to an increased risk for Parkinson’s disease...

    • Read More

    News

    Late-window stroke thrombolysis not linked to clot migration

    Author:
    Sue Hughes
    Publish date: March 3, 2021

    This is the first randomized controlled study to assess the effect of thrombolysis on clot migration and accessibility in an extended time window...

    • Read More

    News

    New steroid dosing regimen for myasthenia gravis

    Author:
    Sue Hughes

    Rapid tapering of prednisone is recommended in patients requiring combined corticosteroid and azathioprine therapy.

    • Read More

    News

    Alien cells may explain COVID-19 brain fog

    Author:
    Sue Hughes

    Occlusion of a multitude of tiny vessels by megalokaryocytes may explain the cognitive issues seen in some patients with COVID-19 infection.

    • Read More

    News

    PFO closure reduces migraine: New meta-analysis

    Author:
    Sue Hughes

    PFO closure significantly reduced the mean number of monthly migraine days and monthly migraine attacks.

    • Read More

    News

    Idiopathic intracranial hypertension is on the rise

    Author:
    Sue Hughes

    “The increasing incidence has important implications for health care professionals and policy makers in addressing the associated comorbidities...

    • Read More

    News

    Stem cell transplant shows long-term benefit in MS

    Author:
    Sue Hughes

    “Autologous hematopoietic stem cell transplant should be considered as a treatment strategy for MS not responding to conventional therapy.”

    • Read More

    Pages

    • « first
    • …
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery